IN-VIVO EVALUATION OF SPRAY FORMULATIONS OF HUMAN INSULIN FOR NASAL DELIVERY

被引:40
作者
DONDETI, P [1 ]
ZIA, HS [1 ]
NEEDHAM, TE [1 ]
机构
[1] UNIV RHODE ISL,COLL PHARM,DEPT PHARMACEUT,KINGSTON,RI 02881
关键词
INSULIN; HUMAN; NASAL ADMINISTRATION; SPRAY FORMULATION; BIOADHESIVE POLYMER; MICROCRYSTALLINE CELLULOSE; PLASTOID; AMMONIUM GLYCYRRHIZINATE; GLYCYRRHETINIC ACID; SODIUM TAUROCHOLATE;
D O I
10.1016/0378-5173(95)00045-K
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
There are many ongoing investigations to improve the nasal bioavailability of peptide and protein formulations. The presence of bioadhesive polymers in nasal formulations may increase the residence time of the drugs in the nasal cavity. A combination of bioadhesive polymers with permeation enhancers would seem to further improve nasal bioavailability. In this study, insulin spray formulations containing two bioadhesive polymers (1.5% w/v microcrystalline cellulose (MCC) and 70% w/w Plastoid L50) alone or in combination with the enhancers such as sodium taurocholate (ST), ammonium glycyrrhizinate (AG) or glycyrrhetinic acid (GA) at 1% w/v level, were evaluated in diabetic rabbits. A total volume of 100 mu l of freshly prepared insulin formulation was sprayed into the nasal cavity of each diabetic rabbit. Glucose levels were monitored using a blood glucose assay and serum insulin levels were analyzed using RIA. 5 U/kg insulin in the MCC suspension alone resulted in an absolute bioavailability of 1.96% while Plastoid L50 alone resulted in 2.25% absolute bioavailability. Insulin in the MCC suspension and ST, AG or GA resulted in 8.36, 7.83 and 2.15% bioavailability, respectively. The same formulations produced a hypoglycemic effect in terms of total glucose reductions of 39.12, 15.96 and 9.36% and the maximal decreases in glucose levels were 58.37, 21.8 and 18.61%, respectively. The Plastoid formulation containing 1% ST provided nasal insulin bioavailability of 5.9% with a total glucose reduction of 17.03% and a maximal glucose decrease of 26.56%. Insulin spray formulations containing 1% ST alone and 1% AG alone resulted in bioavailabilities of 7.25 and 3.57%, respectively. These same sprays provided total glucose reductions of 25.08 and 16.97% with maximal glucose decreases of 44.56 and 19.81%, respectively. The presence of benzalkonium chloride and 2-phenylethanol as preservatives in the MCC suspension resulted in higher insulin absorption than the same formulation without preservatives (6.31% vs 1.96%).
引用
收藏
页码:91 / 105
页数:15
相关论文
共 56 条
  • [11] BILE-SALTS AND INTRANASAL DRUG ABSORPTION
    DUCHATEAU, GSMJE
    ZUIDEMA, J
    MERKUS, FWHM
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 31 (03) : 193 - 199
  • [12] GEURKINK N, 1983, J ALLERGY CLIN IMMUN, V72, P123, DOI 10.1016/0091-6749(83)90518-3
  • [13] GIBALDI M, 1970, FED PROC, V29, P1343
  • [14] MECHANISMS OF SURFACTANT EFFECTS ON DRUG ABSORPTION
    GIBALDI, M
    FELDMAN, S
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1970, 59 (05) : 579 - +
  • [15] NASAL ABSORPTION OF INSULIN - ENHANCEMENT BY HYDROPHOBIC BILE-SALTS
    GORDON, GS
    MOSES, AC
    SILVER, RD
    FLIER, JS
    CAREY, MC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (21) : 7419 - 7423
  • [16] INTRANASAL DRUG DELIVERY BY SPRAY AND DROPS
    HARDY, JG
    LEE, SW
    WILSON, CG
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1985, 37 (05) : 294 - 297
  • [17] Review: Clinical Opportunities Provided by the Nasal Administration of Peptides
    Harris, A. S.
    [J]. JOURNAL OF DRUG TARGETING, 1993, 1 (02) : 101 - 116
  • [18] EFFECT OF VISCOSITY ON PARTICLE-SIZE, DEPOSITION, AND CLEARANCE OF NASAL DELIVERY SYSTEMS CONTAINING DESMOPRESSIN
    HARRIS, AS
    SVENSSON, E
    WAGNER, ZG
    LETHAGEN, S
    NILSSON, IM
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1988, 77 (05) : 405 - 408
  • [19] EFFECTS OF CONCENTRATION AND VOLUME ON NASAL BIOAVAILABILITY AND BIOLOGICAL RESPONSE TO DESMOPRESSIN
    HARRIS, AS
    OHLIN, M
    LETHAGEN, S
    NILSSON, IM
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1988, 77 (04) : 337 - 339
  • [20] EFFECT OF VISCOSITY ON THE PHARMACOKINETICS AND BIOLOGICAL RESPONSE TO INTRANASAL DESMOPRESSIN
    HARRIS, AS
    OHLIN, M
    SVENSSON, E
    LETHAGEN, S
    NILSSON, IM
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1989, 78 (06) : 470 - 471